Research

In this research letter recently published in JAMA, the authors assessed persistent symptoms in patients who had been discharged from hospital after recovery from COVID-19.

Anosmia, stroke, paralysis, cranial nerve deficits, encephalopathy, delirium, meningitis, and seizures are some of the neurological complications in patients with COVID-19.

In this study, recently published in Brain, the authors present cerebrovascular disease case incidence in hospitalised patients with SARS-CoV-2 infection.

In this paper, the authors retrospectively reviewed all COVID-19–positive patients admitted to the neuroscience intensive care unit for monitoring of malignant cerebral oedema

In this paper recently published in Acta Neuropathologica, the authors report neuropathology of two COVID-19 patients.

In this paper, the authors pooled all consecutive patients hospitalised with laboratory-confirmed COVID-19 and acute ischaemic stroke across 28 sites from 16 countries.

In this paper, the authors report a case of a previously healthy 58-year-old man who acutely developed hyposmia, generalised myoclonus, fluctuating and transient changes in level of consciousness, opsoclonus and an asymmetric hypokinetic-rigid syndrome with ocular abnormalities following severe SARS-CoV-2 infection.

In this review recently published in JAMA, the authors summarise the current evidence regarding the pathophysiology, transmission, diagnosis, and management of COVID-19.

In this multicentre retrospective observational study, the authors analysed the impact of the COVID-19 pandemic on hospital stroke admissions and in-hospital mortality in tertiary referral hospitals in north-west Spain.

In this paper recently published in the official journal of the Hungarian Society of Neurologists, the authors discuss neurological signs and symptoms in COVID-19 patients; the effects of COVID-19 on services for other acute diseases; and changes in the care for patients with chronic neurological disorders.

In this review prepared by the Turkish Neurological Society COVID- 19 Committee, and recently published in the Turkish Journal of Neurology, the authors discuss multiple neurological aspects relating to COVID-19.

The aim of this retrospective, observational cohort study, published in Lancet Rheumatology, was to assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and death in patients with severe COVID-19 pneumonia who received standard of care treatment.

The objective of this retrospective multicentre cohort study was to investigate new-onset neurological impairment associated with COVID-19.

The objective of this cross-sectional observational study was to estimate the incidence and fatality of COVID-19 and identify potential risk factors to fatality in patients with active epilepsy.

The objective of this study was to report outcomes on patients with multiple sclerosis (MS) and related disorders with COVID-19 illness. From March 16 to April 30, 2020, patients with MS or related disorders at NYU Langone MS Comprehensive Care Center were identified with either laboratory-confirmed or suspected COVID-19.